Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: Usefulness of leptin for the treatment of obesity-associated diabetes

Hiroaki Masuzaki, Yoshihiro Ogawa, Megumi Aizawa-Abe, Kiminori Hosoda, Junko Suga, Ken Ebihara, Noriko Satoh, Hidenori Iwai, Gen Inoue, Haruo Nishimura, Yasunao Yoshimasa, Kazuwa Nakao

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Leptin acts as an adipocyte-derived blood-borne satiety factor that can increase glucose metabolism. To elucidate the therapeutic implications of leptin for obesity-associated diabetes, we crossed transgenic skinny mice overexpressing leptin (Tg/+), which we have developed recently, and lethal yellow KK(y) mice (A(y)/+), a genetic model for obesity-diabetes syndrome, and examined the metabolic phenotypes of F1 animals. At 6 weeks of age, plasma leptin concentrations in Tg/+ mice with the A(y) allele (Tg/+:A(y)/+) were significantly higher than those in A(y)/+ mice. Although no significant differences in body weight were noted among Tg/+:A(y)/+ mice, A(y)/+ mice, and their wild-type lean littermates (+/+), glucose and insulin tolerance tests revealed increased glucose tolerance and insulin sensitivity in Tg/+:A(y)/+ compared with A(y)/+ mice. However, at 12 weeks of age, when plasma leptin concentrations in A(y)/+ mice were comparable to those in Tg/+:A(y)/+ mice, Tg/+:A(y)/+ mice developed obesity-diabetes syndrome similar to that of A(y)[+ mice. Body weights of 12-week-old Tg/+:A(y)/+ and A(y)/+ mice were reduced to those of +/+ mice by a 3-week food restriction; when plasma leptin concentrations remained high in Tg/+:A(y)/+ mice but were markedly reduced in A(y)/+ and +/+ mice, glucose tolerance and insulin sensitivity in Tg/+:A(y)/+ mice were markedly improved as compared with A(y)/+ and +/+ mice. The present study demonstrates that hyperleptinemia can delay the onset of impaired glucose metabolism and accelerate the recovery from diabetes during caloric restriction in Tg/+:A(y)/+ mice, thereby suggesting the potential usefulness of leptin in combination with a long- term caloric restriction for the treatment of obesity-associated diabetes.

Original languageEnglish
Pages (from-to)1615-1622
Number of pages8
JournalDiabetes
Volume48
Issue number8
DOIs
Publication statusPublished - Aug 1 1999
Externally publishedYes

Fingerprint

Leptin
Transgenic Mice
Insulin Resistance
Obesity
Glucose
Mutation
Therapeutics
Caloric Restriction
Dasyproctidae
Body Weight
Genetic Models
Glucose Tolerance Test
Adipocytes

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation : Usefulness of leptin for the treatment of obesity-associated diabetes. / Masuzaki, Hiroaki; Ogawa, Yoshihiro; Aizawa-Abe, Megumi; Hosoda, Kiminori; Suga, Junko; Ebihara, Ken; Satoh, Noriko; Iwai, Hidenori; Inoue, Gen; Nishimura, Haruo; Yoshimasa, Yasunao; Nakao, Kazuwa.

In: Diabetes, Vol. 48, No. 8, 01.08.1999, p. 1615-1622.

Research output: Contribution to journalArticle

Masuzaki, H, Ogawa, Y, Aizawa-Abe, M, Hosoda, K, Suga, J, Ebihara, K, Satoh, N, Iwai, H, Inoue, G, Nishimura, H, Yoshimasa, Y & Nakao, K 1999, 'Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: Usefulness of leptin for the treatment of obesity-associated diabetes', Diabetes, vol. 48, no. 8, pp. 1615-1622. https://doi.org/10.2337/diabetes.48.8.1615
Masuzaki, Hiroaki ; Ogawa, Yoshihiro ; Aizawa-Abe, Megumi ; Hosoda, Kiminori ; Suga, Junko ; Ebihara, Ken ; Satoh, Noriko ; Iwai, Hidenori ; Inoue, Gen ; Nishimura, Haruo ; Yoshimasa, Yasunao ; Nakao, Kazuwa. / Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation : Usefulness of leptin for the treatment of obesity-associated diabetes. In: Diabetes. 1999 ; Vol. 48, No. 8. pp. 1615-1622.
@article{8a9da3dfbcde4f4fa059a90577e70533,
title = "Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: Usefulness of leptin for the treatment of obesity-associated diabetes",
abstract = "Leptin acts as an adipocyte-derived blood-borne satiety factor that can increase glucose metabolism. To elucidate the therapeutic implications of leptin for obesity-associated diabetes, we crossed transgenic skinny mice overexpressing leptin (Tg/+), which we have developed recently, and lethal yellow KK(y) mice (A(y)/+), a genetic model for obesity-diabetes syndrome, and examined the metabolic phenotypes of F1 animals. At 6 weeks of age, plasma leptin concentrations in Tg/+ mice with the A(y) allele (Tg/+:A(y)/+) were significantly higher than those in A(y)/+ mice. Although no significant differences in body weight were noted among Tg/+:A(y)/+ mice, A(y)/+ mice, and their wild-type lean littermates (+/+), glucose and insulin tolerance tests revealed increased glucose tolerance and insulin sensitivity in Tg/+:A(y)/+ compared with A(y)/+ mice. However, at 12 weeks of age, when plasma leptin concentrations in A(y)/+ mice were comparable to those in Tg/+:A(y)/+ mice, Tg/+:A(y)/+ mice developed obesity-diabetes syndrome similar to that of A(y)[+ mice. Body weights of 12-week-old Tg/+:A(y)/+ and A(y)/+ mice were reduced to those of +/+ mice by a 3-week food restriction; when plasma leptin concentrations remained high in Tg/+:A(y)/+ mice but were markedly reduced in A(y)/+ and +/+ mice, glucose tolerance and insulin sensitivity in Tg/+:A(y)/+ mice were markedly improved as compared with A(y)/+ and +/+ mice. The present study demonstrates that hyperleptinemia can delay the onset of impaired glucose metabolism and accelerate the recovery from diabetes during caloric restriction in Tg/+:A(y)/+ mice, thereby suggesting the potential usefulness of leptin in combination with a long- term caloric restriction for the treatment of obesity-associated diabetes.",
author = "Hiroaki Masuzaki and Yoshihiro Ogawa and Megumi Aizawa-Abe and Kiminori Hosoda and Junko Suga and Ken Ebihara and Noriko Satoh and Hidenori Iwai and Gen Inoue and Haruo Nishimura and Yasunao Yoshimasa and Kazuwa Nakao",
year = "1999",
month = "8",
day = "1",
doi = "10.2337/diabetes.48.8.1615",
language = "English",
volume = "48",
pages = "1615--1622",
journal = "Diabetes",
issn = "0012-1797",
publisher = "医学出版",
number = "8",

}

TY - JOUR

T1 - Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation

T2 - Usefulness of leptin for the treatment of obesity-associated diabetes

AU - Masuzaki, Hiroaki

AU - Ogawa, Yoshihiro

AU - Aizawa-Abe, Megumi

AU - Hosoda, Kiminori

AU - Suga, Junko

AU - Ebihara, Ken

AU - Satoh, Noriko

AU - Iwai, Hidenori

AU - Inoue, Gen

AU - Nishimura, Haruo

AU - Yoshimasa, Yasunao

AU - Nakao, Kazuwa

PY - 1999/8/1

Y1 - 1999/8/1

N2 - Leptin acts as an adipocyte-derived blood-borne satiety factor that can increase glucose metabolism. To elucidate the therapeutic implications of leptin for obesity-associated diabetes, we crossed transgenic skinny mice overexpressing leptin (Tg/+), which we have developed recently, and lethal yellow KK(y) mice (A(y)/+), a genetic model for obesity-diabetes syndrome, and examined the metabolic phenotypes of F1 animals. At 6 weeks of age, plasma leptin concentrations in Tg/+ mice with the A(y) allele (Tg/+:A(y)/+) were significantly higher than those in A(y)/+ mice. Although no significant differences in body weight were noted among Tg/+:A(y)/+ mice, A(y)/+ mice, and their wild-type lean littermates (+/+), glucose and insulin tolerance tests revealed increased glucose tolerance and insulin sensitivity in Tg/+:A(y)/+ compared with A(y)/+ mice. However, at 12 weeks of age, when plasma leptin concentrations in A(y)/+ mice were comparable to those in Tg/+:A(y)/+ mice, Tg/+:A(y)/+ mice developed obesity-diabetes syndrome similar to that of A(y)[+ mice. Body weights of 12-week-old Tg/+:A(y)/+ and A(y)/+ mice were reduced to those of +/+ mice by a 3-week food restriction; when plasma leptin concentrations remained high in Tg/+:A(y)/+ mice but were markedly reduced in A(y)/+ and +/+ mice, glucose tolerance and insulin sensitivity in Tg/+:A(y)/+ mice were markedly improved as compared with A(y)/+ and +/+ mice. The present study demonstrates that hyperleptinemia can delay the onset of impaired glucose metabolism and accelerate the recovery from diabetes during caloric restriction in Tg/+:A(y)/+ mice, thereby suggesting the potential usefulness of leptin in combination with a long- term caloric restriction for the treatment of obesity-associated diabetes.

AB - Leptin acts as an adipocyte-derived blood-borne satiety factor that can increase glucose metabolism. To elucidate the therapeutic implications of leptin for obesity-associated diabetes, we crossed transgenic skinny mice overexpressing leptin (Tg/+), which we have developed recently, and lethal yellow KK(y) mice (A(y)/+), a genetic model for obesity-diabetes syndrome, and examined the metabolic phenotypes of F1 animals. At 6 weeks of age, plasma leptin concentrations in Tg/+ mice with the A(y) allele (Tg/+:A(y)/+) were significantly higher than those in A(y)/+ mice. Although no significant differences in body weight were noted among Tg/+:A(y)/+ mice, A(y)/+ mice, and their wild-type lean littermates (+/+), glucose and insulin tolerance tests revealed increased glucose tolerance and insulin sensitivity in Tg/+:A(y)/+ compared with A(y)/+ mice. However, at 12 weeks of age, when plasma leptin concentrations in A(y)/+ mice were comparable to those in Tg/+:A(y)/+ mice, Tg/+:A(y)/+ mice developed obesity-diabetes syndrome similar to that of A(y)[+ mice. Body weights of 12-week-old Tg/+:A(y)/+ and A(y)/+ mice were reduced to those of +/+ mice by a 3-week food restriction; when plasma leptin concentrations remained high in Tg/+:A(y)/+ mice but were markedly reduced in A(y)/+ and +/+ mice, glucose tolerance and insulin sensitivity in Tg/+:A(y)/+ mice were markedly improved as compared with A(y)/+ and +/+ mice. The present study demonstrates that hyperleptinemia can delay the onset of impaired glucose metabolism and accelerate the recovery from diabetes during caloric restriction in Tg/+:A(y)/+ mice, thereby suggesting the potential usefulness of leptin in combination with a long- term caloric restriction for the treatment of obesity-associated diabetes.

UR - http://www.scopus.com/inward/record.url?scp=0032768291&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032768291&partnerID=8YFLogxK

U2 - 10.2337/diabetes.48.8.1615

DO - 10.2337/diabetes.48.8.1615

M3 - Article

C2 - 10426381

AN - SCOPUS:0032768291

VL - 48

SP - 1615

EP - 1622

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 8

ER -